SkinHealth Systems (SKIN) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
10 Jun, 2026Opening remarks and agenda
Meeting called to order by the chairman, with introductions of key management and election inspector.
Only stockholders of record as of April 16, 2026, were eligible to vote.
Agenda included director elections, auditor ratification, and executive compensation advisory vote.
Board and executive committee updates
Nine director nominees were presented for election, with no additional nominations received.
Shareholder proposals
Three proposals presented: election of directors, ratification of Deloitte & Touche LLP as auditor, and advisory vote on executive compensation.
Board recommended voting in favor of all proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from SkinHealth Systems
- Shareholders to vote on a reverse stock split and possible meeting adjournment on Sept 22, 2026.SKIN
Proxy filing - Shareholders will vote on a reverse stock split to help maintain Nasdaq listing compliance.SKIN
Proxy filing - Q2 2026 sales fell 7.8%, but margins and EBITDA improved amid ongoing market challenges.SKIN
Q2 2026 - Vote sought on a reverse stock split to maintain Nasdaq listing and increase share price.SKIN
Proxy filing - Adjusted EBITDA rose to $8.5M as sales fell and guidance was lowered amid market headwinds.SKIN
Q1 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with focus on governance and ESG.SKIN
Proxy filing - Margins and profitability improved in 2025, with stable outlook and growth expected in 2027.SKIN
Q4 2025 - Gross margin rebounded to 51.6% in Q3 2024 despite a 19.1% sales decline.SKIN
Q3 2024 - Net sales dropped 22.9% as device sales lagged, prompting a downward revision to 2024 guidance.SKIN
Q2 2024